|9.53 -0.17 (-1.75%)||12-08 11:50|
|Targets||6-month :||11.32||1-year :||13.23|
|Resists||First :||9.69||Second :||11.32|
|Supports||First :||9.3||Second :||9.06|
|MAs||MA(5) :||9.62||MA(20) :||9.44|
|MA(100) :||9.33||MA(250) :||9.08|
|MACD||MACD :||0||Signal :||0|
|%K %D||K(14,3) :||81||D(3) :||89.4|
|52-week||High :||10.47||Low :||7.51|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SSIC ] has closed below upper band by 45.2%. Bollinger Bands are 44.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
|If tomorrow:||Open lower||Open higher|
|High:||9.66 - 9.72||9.72 - 9.76|
|Low:||9.38 - 9.46||9.46 - 9.52|
|Close:||9.43 - 9.54||9.54 - 9.62|
Silver Spike Investment Corp., is a a business development company. It is a specialty finance company, focuses on investing across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately held cannabis companies. It intends to partner with private equity firms, entrepreneurs, business owners, and management teams to provide credit and equity financing alternatives to support buyouts, recapitalizations, growth initiatives, refinancings, and acquisitions across cannabis companies, including cannabis-enabling technology companies, cannabis-related health and wellness companies, and hemp and CBD distribution companies. The company was founded in 2021 and is based in New York, New York.
Wed, 08 Nov 2023
Small-Cap Value List Details - MSN
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Drug Manufacturers—Specialty & Generic
|Shares Out||6 (M)|
|Shares Float||0 (M)|
|Held by Insiders||0.4 (%)|
|Held by Institutions||77.9 (%)|
|Shares Short||3 (K)|
|Shares Short P.Month||4 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||14.06|
|Profit Margin||58.7 %|
|Operating Margin||55.4 %|
|Return on Assets (ttm)||0 %|
|Return on Equity (ttm)||0 %|
|Qtrly Rev. Growth||147.1 %|
|Gross Profit (p.s.)||0.86|
|Sales Per Share||1.87|
|Qtrly Earnings Growth||127.5 %|
|Operating Cash Flow||-43 (M)|
|Levered Free Cash Flow||0 (M)|
|Price to Book value||0.67|
|Price to Sales||5.07|
|Price to Cash Flow||-1.37|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|